3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
16
Neoplasms
11
Pancreatic Neoplasms
10
Prostatic Neoplasms
7
Glioma
6
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Head and Neck Neoplasms
5
Glioblastoma
5
Carcinoma, Non-Small-Cell Lung
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Polycystic Ovary Syndrome
4
Colonic Neoplasms
4
Obesity
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Brain Neoplasms
3
Pain, Postoperative
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Depression
2
Cholangiocarcinoma
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Interventions
Tetracycline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Withdrawn
×
Chalazion
×
Clear all
NCT01763437
2017-01-12
TET
The Cleveland Clinic
Phase EARLY_PHASE1
Withdrawn